| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 8, 1336-1346, Copyright © 1994 by Endocrine Society
ARTICLES |
E Vig, TJ Barrett and WV Vedeckis
Department of Biochemistry and Molecular Biology, Louisiana State University Medical Center, New Orleans 70112.
Autologous regulation of steroid receptors by their cognate ligands has been demonstrated for a number of nuclear receptor family members. To determine the molecular mechanism for glucocorticoid receptor (GR) autoregulation, the expression of glucocorticoid receptor mRNA and protein levels were examined in the mouse AtT-20 pituitary tumor cell line. The expression of c-jun and c-fos mRNA and protein was also examined in the same cell extracts. A rapid down-regulation of the GR protein was observed after treatment with the glucocorticoid analog, triamcinolone acetonide (TA). An oscillatory, parallel regulation of both GR and c-jun mRNA levels occurred. In contrast, POMC mRNA levels remained at a stable, low level during chronic TA treatment. Dose- response analyses also revealed a coordinate down-regulation of GR and c-jun (but not POMC or c-fos) mRNA levels. FOS protein levels were unaffected by TA treatment. Surprisingly, JUN protein levels were increased by TA, even when the c-jun mRNA levels were decreasing. Perhaps a derepression of c-jun mRNA translation occurs after TA treatment, and this may be due to GR/JUN heteromer formation interfering with JUN repression of c-jun mRNA translation. The effect of TA on GR and c-jun gene expression was a primary effect, as it occurred rapidly and was not inhibited by cycloheximide (CHX). Nuclear run-on transcription assays revealed a rapid (15 min) down-regulation in both GR and c-jun gene transcription rates, while POMC gene transcription was unaffected at this early time. Treatment of AtT-20 cells with all-trans retinoic acid gave different kinetics for GR and c- jun mRNA regulation than obtained with TA; however, the GR and c-jun mRNA levels were still coordinately regulated after retinoic acid treatment. Based upon these data, the promoter structures of the GR and c-jun genes, and previously published results, a novel mechanism for the coupled regulation of GR and c-jun transcription, via a direct transcriptional interference with AP-1 (FOS/JUN) activity, is proposed.
This article has been cited by other articles:
![]() |
A. Hagendorf, J. W. Koper, F. H. de Jong, A. O. Brinkmann, S. W. J. Lamberts, and R. A. Feelders Expression of the Human Glucocorticoid Receptor Splice Variants {alpha}, {beta}, and P in Peripheral Blood Mononuclear Leukocytes in Healthy Controls and in Patients with Hyper- and Hypocortisolism J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6237 - 6243. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-d. Geng and W. V. Vedeckis Steroid-Responsive Sequences in the Human Glucocorticoid Receptor Gene 1A Promoter Mol. Endocrinol., April 1, 2004; 18(4): 912 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Terzic, M. Vujcic, A. Ristic-Fira, M. Krstic-Demonacos, D. Milanovic, D. T. Kanazir, and S. Ruzdijic Effects of Age and Dexamethasone Treatment on Glucocorticoid Response Element and Activating Protein-1 Binding Activity in Rat Brain J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2003; 58(4): B297 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pujols, J. Mullol, M. Pérez, J. Roca-Ferrer, M. Juan, A. Xaubet, J. A. Cidlowski, and C. Picado Expression of the Human Glucocorticoid Receptor {alpha} and {beta} Isoforms in Human Respiratory Epithelial Cells and Their Regulation by Dexamethasone Am. J. Respir. Cell Mol. Biol., January 1, 2001; 24(1): 49 - 57. [Abstract] [Full Text] |
||||
![]() |
B. Spindler and F. Verrey Aldosterone action: induction of p21ras and fra-2 and transcription-independent decrease in myc, jun, and fos Am J Physiol Cell Physiol, May 1, 1999; 276(5): C1154 - C1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ramdas, W. Liu, and J. M. Harmon Glucocorticoid-induced Cell Death Requires Autoinduction of Glucocorticoid Receptor Expression in Human Leukemic T Cells Cancer Res., March 1, 1999; 59(6): 1378 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wei, N. Inamdar, and W. V. Vedeckis Transrepression of c-jun Gene Expression by the Glucocorticoid Receptor Requires Both AP-1 Sites in the c-jun Promoter Mol. Endocrinol., September 1, 1998; 12(9): 1322 - 1333. [Abstract] [Full Text] |
||||
![]() |
A. H. Lauber, T. J. Barrett, M. Subramaniam, M. Schuchard, and T. C. Spelsberg A DNA-binding Element for a Steroid Receptor-binding Factor Is Flanked by Dual Nuclear Matrix DNA Attachment Sites in the c-myc Gene Promoter J. Biol. Chem., September 26, 1997; 272(39): 24657 - 24665. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Iredale and R. S. Duman Glucocorticoid Regulation of Corticotropin-Releasing Factor1 Receptor Expression in Pituitary-Derived AtT-20 Cells Mol. Pharmacol., May 1, 1997; 51(5): 794 - 799. [Abstract] [Full Text] |
||||
![]() |
J. C. Webster, R. H. Oakley, C. M. Jewell, and J. A. Cidlowski Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: A mechanism for the generation of glucocorticoid resistance PNAS, June 5, 2001; 98(12): 6865 - 6870. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |